Effects of Changtai granules, a traditional compound Chinese medicine, on chronic trinitrobenzene sulfonic acid-induced colitis in rats

World Journal of Gastroenterology

Volumn 11, Issue 23, 2005, Pages 3539-3543

  Cao, Yong Bing ^a   Zhang, Jun Dong ^a   Diao, Ya Ying ^b   Yan, Lan ^a   Wang, De Jun ^a   Jia, Xin Ming ^a   Gao, Ping Hui ^a   Cheng, Ming He ^a   Xu, Zheng ^a   Wang, Yan ^a   Jiang, Yuan Ying ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

2,4,6 trinitrobenzene sulfonic acid; Changtai granules; Myeloperoxidase; Ulcerative colitis

Indexed keywords

CHANGTAI GRANULE; CHINESE DRUG; DEXAMETHASONE; MYELOPEROXIDASE; SODIUM CHLORIDE; TRINITROBENZENESULFONIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; CHINESE MEDICINE; COLITIS; CONTROLLED STUDY; DIARRHEA; DRUG DOSE REGIMEN; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; FREQUENCY ANALYSIS; GRANULOCYTE; HISTOLOGY; INFLAMMATION; INTESTINE ULCER; MACROPHAGE; MALE; MONOCYTE; MORTALITY; NONHUMAN; RANDOMIZATION; RAT; RAT STRAIN;

EID: 21344466324     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i23.3539     Document Type: Article

References (34)

1. Farrokhyar F, Swarbrick ET, Irvine EJ. A critical review of epidemiological studies in inflammatory bowel disease. Scand J Gastroenterol 2001; 36: 2-15
2. Karlinger K, Gyorke T, Mako E, Mester A, Tarjan Z. The epidemiology and the pathogenesis of inflammatory bowel disease. Eur J Radiol 2000; 35: 154-167
3. Cottone M, Martorana G, Di Mitri R, Camma C, Caprilli R. Epidemiology of inflammatory bowel disease in Italy. Ital J Gastroenterol Hepatol 1999; 31: 503-507
4. Hugot JP, Zouali H, Lesage S, Thomas G. Etiology of the inflammatory bowel diseases. Int J Colorectal Dis 1999; 14: 2-9
5. Furrie E, Macfarlane S, Cummings JH, Macfarlane GT. Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response. Gut 2004; 53: 91-98
6. Ioachim E, Michael M, Katsanos C, Demou A, Tsianos EV. The immunohistochemical expression of metallothionein in inflammatory bowel disease. Correlation with HLA-DR antigen expression, lymphocyte subpopulations and proliferation-associated indices. Histol Histopathol 2003; 18: 75-82
7. Ludwiczek O, Kaser A, Tilg H. Plasma levels of soluble CD40 ligand are elevated in inflammatory bowel diseases. Int J Colorectal Dis 2003; 18: 142-147
8. Sawada-Hase N, Kiyohara T, Miyagawa J, Ueyama H, Nishibayashi H, Murayama Y, Kashihara T, Nakahara M, Miyazaki Y, Kanayama S, Nezu R, Shinomura Y, Matsuzawa Y. An increased number of CD40-high monocytes in patients with Crohn's disease. Am J Gastroenterol 2000; 95: 1516-1523
9. Candelli M, Nista EC, Nestola M, Armuzzi A, Silveri NG, Gasbarrini G, Gasbarrini A. Saccharomyces cerevisiae-associated diarrhea in an immunocompetent patient with ulcerative colitis. J Clin Gastroenterol 2003; 36: 39-40
10. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347: 417-429
11. Delco F, Sonnenberg A. Commonalities in the time trends of Crohn's disease and ulcerative colitis. Am J Gastroenterol 1999; 94: 2171-2176
12. Stewenius J, Adnerhill I, Ekelund G, Floren CH, Fork FT, Janzon L, Lindstrom C, Mars I, Nyman M, Rosengren JE. Ulcerative colitis and indeterminate colitis in the city of Malmo, Sweden. A 25-year incidence study. Scand J Gastroenterol 1995; 30: 38-43
13. Friedman S, Rubin PH, Bodian C, Goldstein E, Harpaz N, Present DH. Screening and surveillance colonoscopy in chronic Crohn's colitis. Gastroenterology 2001; 120: 820-826
14. Munkholm P. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther 2003; 18(Suppl 2): 1-5
15. Kunisaki Y, Goto H, Kitagawa K, Nagano M. Salazosulfa-pyridine induced hypersensitivity syndrome associated with reactivation of humanherpes virus 6. Intern Med 2003; 42: 203-207
16. Cheng WJ. Clinical observation on treatment of ulcerative colitis by soothing liver and activating spleen. Zhongguo Zhongxiyi Jiehe Zazhi 2001; 21: 34-36
17. Moum B. Medical treatment: does it influence the natural course of inflammatory bowel disease? Eur J Intern Med 200; 11: 197-203
18. Katz JA. Treatment of inflammatory bowel disease with corticosteroids. Gastroenterol Clin North Am 2004; 33: 171-189
19. Jahnsen J, Falch JA, Mowinckel P, Aadland E. Bone mineral density in patients with inflammatory bowel disease: a population-based prospective two-year follow-up study. Scand J Gastroenterol 2004; 39: 145-153
20. Duerr RH. The genetics of inflammatory bowel disease. Gastroenterol Clin North Am 2002; 31: 63-76
21. Shen B. Diagnosis and treatment of patients with pouchitis. Drugs 2003; 63: 453-461
22. Sood A, Midha V, Sood N, Malhotra V. Adult celiac disease in northern India. Indian J Gastroenterol 2003; 22: 124-126
23. Jiang XL, Quan QZ, Sun ZQ, Wang YJ, Qi F. Effect of glucocorticoid on lymphocyte adhesion molecule phenotype expression in patients with ulcerative colitis. Zhongguo Weizhongbing Jijiu Yixue 1998; 10: 366-368
24. Jiang XL, Quan QZ, Sun ZQ, Wang YJ, Qi F. Relationship between syndrome-typing of ulcerative colitis and activation of platelet. Zhongyi Zazhi 1997; 38: 730-731
25. Jiang XL, Wang ZK, Qin CY. Current research and strategy on ulcerative colitis in China. Shijie Huaren Xiaohua Zazhi 2000; 8: 610-613
26. Jiang XL, Quan QZ, Dong XC, Liu T. Effects of houttuynia herb on rectual and annual motility in patients with ulcerative colitis. Zhongyiyao Xuebao 2000; 4: 43-44
27. Cheng WJ. Clinical observation on treatment of ulcerative colitis by soothing liver and activating spleen. Zhongguo Zhongxiyi Jiehe Zazhi 2001; 21: 34-36
28. Meng M. TCM differential treatment of 57 cases of chronic gastritis complicated by ulcerative colitis. J Tradit Chin Med 1999; 19: 10-15
29. Wang YL, Li XH, Zhang H. Study of treating experimental ulcerative colitis of spleen deficiency type with "guben yichang tablet" in guinea pigs. Zhongguo Zhongxiyi Jiehe Zazhi 1995; 15: 98-100
30. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96: 795-803
31. Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984; 87: 1344-1350
32. Elson CO, Sartor RB, Targan SR, Sandborn WJ. Challenges in IBD Research: updating the scientific agendas. Inflamm Bowel Dis 2003; 9: 137-153
33. Mow WS, Vasiliauskas EA, Lin YC, Fleshner PR, Papadakis KA, Taylor KD, Landers CJ, Abreu-Martin MT, Rotter JI, Yang H, Targan SR. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology 2004; 126: 414-424
34. Cao YB, Li LP, Zhang JD, Yan L, Gao PH, Xu Z, Wang Y, Jia XM, Jiang YY. Experimental study on analgesic-antipyretic and anti-inflammatory actions of Changyan Chongji. Pharm Care Res 2004; 4: 22-25